Axikin Pharmaceuticals Garners $2,000,000 New Funding
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=fa3aad53-015c-4399-acc0-89fb3483c562&Preview=1 - Date
3/30/2012 - Company Name
Axikin Pharmaceuticals - Mailing Address
10835 Road To The Cure San Diego, CA 92121 - Company Description
The Axikin discovery biology and portfolio of small molecules focuses on novel GPCR and kinase targets central to the inflammatory process, the antagonism of which is predicted to ameliorate allergic respiratory disorders such as rhinitis and asthma, in addition to significantly impacting the inflammation observed in COPD. - Website
http://www.axikin.com - Transaction Type
Venture Equity - Transaction Amount
$2,000,000 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. - M&A Terms
- Venture Investor
Undisclosed
